Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer

Recruiting now · Not applicable

Conditions studied: Gastric Cancer

In brief

This study intends to explore the value of 68Ga-FAPI-04 and 18F-FDG PET/CT in the evaluation of treatment response to neoadjuvant chemotherapy(NAC) for patients with locally advanced gastric cancer(LAGC).

Key facts

Study ID
NCT05140746
Run by
Ruijin Hospital
People needed
40
Starts
2020-09-10
Expected to finish
2027-09-10
Last updated by the study team
2024-01-09

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.